Pharmacists in Clarksburg, West Virginia


76 Pharmacists found in Clarksburg
female pharmacist

Dr. Stacy Lynn Gould, PHARM.D.


Pharmacist
1 Med Center Dr, Clarksburg, WV 26301
304-623-3461    

female pharmacist

Dr. Stephanie Dare Adams, PHARM.D.


Pharmacist
1 Medical Center Drive, Clarksburg, WV 26301
304-623-3461    

female pharmacist

Susan Michele Rogers, RPH


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
1 Med Center Dr, Clarksburg, WV 26301
304-623-3461     304-623-7690



female pharmacist

Sydnee Hewitt, PHARM D


Pharmacist
198 Emily Dr, Clarksburg, WV 26301
304-623-1482     304-623-1112

female pharmacist

Dr. Sydney Adrienna Bongiorni, PHARMD


Pharmacist
1 Medical Center Drive, Clarksburg, WV 26301
304-623-3461    

female pharmacist

Taylor Nicole Talkington, PHARMD


Pharmacist
1 Med Center Dr, Clarksburg, WV 26301
304-623-3461    

female pharmacist

Teresa Azzopardi, PHARM.D.


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
One Medical Center Drive, Clarksburg, WV 26301
304-623-3461    

female pharmacist

Toni A Hall


Pharmacist
550 Emily Dr, Clarksburg, WV 26301
304-622-2784     304-622-2784

female pharmacist

Dr. Tonya Jimmie, PHARMD


Pharmacist
1 Med Center Dr, Clarksburg, WV 26301
304-623-3461    

male pharmacist

Dr. Ty Garrison, PHARMACIST


Pharmacist
701 E Main St, Clarksburg, WV 26301
304-624-0161    

male pharmacist

Tyler M Zimm


Pharmacist
102 Emily Dr, Clarksburg, WV 26301
623-148-2304    

female pharmacist

Whitney Lynn Riley, RPH


Pharmacist
1 Medical Center Dr, Clarksburg, WV 26301
304-623-3461    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.